Bitcoin is approaching a key support level around $81,000 after facing selling pressure near $86,500, which acted as resistance. Traders are closely monitoring whether Bitcoin can hold the $81,000 support to avoid further declines or if a break below could lead to more selling. The broader market remains mixed, influenced by macroeconomic factors and shifts between Bitcoin and altcoins. The $86,500 level remains a resistance point while $81,000 is critical for short-term direction.
Bitcoin's price action near $81,000 and $86,500 offers context for cryptocurrency market trends. For readers following crypto assets, here is Pluang's market snapshot as of Oct 08, 2026 23:31 WIB: out of 50 major cryptocurrencies, 6 rose and 43 fell today. Notable movers include Balancer (BAL) with a 1-day gain of 11.14% at Rp16.297 and Avalanche (AVAX) down 11.10% at Rp180.779.
NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...
McDonald's raised its quarterly dividend by 4%, marking 50 consecutive years of dividend increases and joining the Dividend Kings. Despite a 2.61% yield and strong free cash flow covering dividends comfortably, the company faces challenges like decli...
RadNet reported a 22.1% revenue increase to $638.3 million and a 23.8% rise in adjusted EBITDA to $105 million for Q3 2026, driven by growth in advanced imaging and digital health segments. The company raised its full-year 2026 guidance for imaging c...
Nvidia's board announced an independent investigation after reports surfaced that CEO Jensen Huang was targeted by a Chinese spy operation through an affair with Alice Huang, a former chip executive allegedly recruited by Chinese intelligence. Jensen...
Regeneron's CIDEB siRNA, a new liver-targeted therapy, showed in a first-in-human trial a rapid and sustained reduction of liver fat by up to 80% in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The treatment also im...
